Skip to main content

MoneyWorks4Me

Glenmark Pharmaceuticals informs about press release

10 Apr 2017 Evaluate

Glenmark Pharmaceuticals has informed about press release titled ‘Glenmark Pharmaceuticals receives ANDA approval for Fenofibrate Capsules USP, 67 mg, 134 mg and 200 mg’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1766.95
Dr. Reddys Labs. 1340.30
Cipla 1370.30
Lupin 1987.50
Zydus Lifesciences 1179.80
View more..